The U.S. Food and Drug Administration has approved the world's only twice-a-year injectable shot designed to prevent HIV, Gilead Sciences announced Wednesday. This marks the first step in an anticipated global rollout that could protect millions.
A Powerful New Option
By delivering protection via two injections each year, this long-acting shot offers a fresh alternative for people at risk. Gilead Sciences hopes the therapy will increase prevention options worldwide.
Global Reach and Equity
While celebrated as a breakthrough, uncertainty surrounds the rollout. It's unclear how many individuals in the U.S. and abroad will gain access to this powerful new option, raising questions about pricing, production and equitable distribution.
Reference(s):
FDA approves the world's only twice-a-year shot to prevent HIV
cgtn.com
